Hospira Gemcitabine Injection (38 mg/mL) 2 g/52.6 mL (US)

Country: Ավստրալիա

language: անգլերեն

source: Department of Health (Therapeutic Goods Administration)

active_ingredient:

gemcitabine hydrochloride, Quantity: 43.27 mg/mL

MAH:

Hospira Australia Pty Ltd

INN:

Gemcitabine hydrochloride

pharmaceutical_form:

Injection, solution

composition:

Excipient Ingredients: sodium hydroxide; hydrochloric acid; water for injections

administration_route:

Intravenous Infusion

units_in_package:

1 x 52.6 mL pack

class:

Medicine Listed (Export Only)

prescription_type:

(S1) This Schedule is intentionally blank

therapeutic_indication:

Ovarian cancer, breast cancer, non small cell lung cancer, pancreatic cancer

leaflet_short:

Visual Identification: A clear, colourless or light straw coloured solution practically free from visible particles; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 18 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Child resistant closure and restricted flow insert

authorization_status:

Licence status A

authorization_date:

2011-11-04